Gelatti, A., Drilon, A., & Santini, F. C. (2019). Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Lung Cancer.
Citação norma ChicagoGelatti, Ana, Alexander Drilon, and Fernando C. Santini. "Optimizing the Sequencing of Tyrosine Kinase Inhibitors (TKIs) in Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer (NSCLC)." Lung Cancer 2019.
Citação norma MLAGelatti, Ana, Alexander Drilon, and Fernando C. Santini. "Optimizing the Sequencing of Tyrosine Kinase Inhibitors (TKIs) in Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer (NSCLC)." Lung Cancer 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.